To the Editor:
The immune system is immature at birth, and environmental exposures are crucial to ensure proper immune maturation. Interestingly, the composition of the gut microbiota in early life is linked to the development of immune-mediated diseases such as allergy. 1 Forkhead box P3 (FOXP3) 1 CD4 regulatory T (Treg) cells control the course and duration of immune responses. A failure in these regulatory processes could lead to exaggerated immune responses, host damage, and immune-mediated diseases such as allergy.
2,3 IL-10-producing Treg cells are present in the human colon and suggested to suppress inflammatory responses, indicating a connection between the microbiota and Treg cell-function. 4 Also, peripheral Treg cells are educated by the colonic microbiota 5 and microbiota-derived metabolites affect Treg cell-function and generation in the periphery. 6 Today, we know very little about FOXP3
1 CD4 T-cell function during early childhood because most studies have been conducted on cord blood, which indeed is informative of the immune status in utero but not of postnatal life, when the child has been directly exposed to environmental factors such as the microbiota.
Lactobacilli are present in the infant gut and correlate with a lower risk of allergy later in life. 7 In addition, lactobacilli dampen in vitro immune activation induced by Staphylococcus aureus (S aureus), a bacterium prevalent in the gut in early life and associated with enhanced immune activation. 8, 9 Here, we investigated the maturation of peripheral CD4
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low T cells in early life in a cross-sectional study, and whether colonization with lactobacilli and S aureus during infancy associates with the maturation and functional responses of FOXP3 1 cells at 2 years of age. Furthermore, we studied how soluble products from these bacteria affect FOXP3
1 cells in vitro. PBMCs from 25 two-year-old children were selected from a prospective birth cohort. Children were included on the basis of the presence of DNA from S aureus and a group of Lactobacillus (L) strains (L rhamnosus, L casei, L paracasei) in fecal samples at 3 occasions during infancy: age 1 week, 2 weeks, and 2 months. 7 In addition, PBMCs from healthy donors were collected at birth (cord blood, n 5 12), 7 years of age (n 5 15), and adulthood (n 5 19) to investigate immune maturation. For some experiments, naive CD4 T cells or CD14 1 monocytes were isolated by magnetic separation. PBMC or isolated cell populations were analyzed after 2 hours of resting (basal phenotyping) or after 24-hour stimulation with cell-free supernatants (CFSs) derived from S aureus 161:2 and/or L reuteri DSM 17938. Secreted cytokine levels in PBMC cultures were measured with ELISA. For a complete description of subjects, materials, and methods, see this article's Online Repository at www.jacionline.org.
To characterize the FOXP3
1 CD4 T-cell population during childhood, we investigated these cells in CBMCs and in PBMCs from children at 2 and 7 years of age and from adults by flow cytometry. There were no differences in the percentage of FOXP3
1 cells within the CD4 T-cell population between the investigated age groups. Within the FOXP3 1 population, the percentage of CD45RA 1 cells significantly decreased after 2 years of age. The percentage of HELIOS 1 cells seemed to decline with age, supporting the idea that HELIOS expression could represent thymic origin 10 (Fig 1, A; 
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low cells among the CD4 Tcell population in all age groups in all but 1 individual (Fig 1, B ; Fig E1, B) . There were lower percentages of FOXP3
1 cells with an early (24-hour) expression of IL-10, IFN-g, and IL-17A in children than in adults (Fig 1, B; Fig E1, C) . We speculated that this could depend on the higher percentage of naive CD4 T cells in children. Because low cell numbers precluded kinetic analyses of the infant cell responses, we purified naive CD4 T cells from healthy adult donors and could show that following stimulation, these naive cells produced less cytokines (data not shown) and had a lower induction of both FOXP3 and the T H 1 transcription factor T-bet compared with CD4 1 T cells in PBMC cultures (Fig 1, C) . Naive cells did not express ROR-gt (T H 17) or GATA-3 (T H 2) (Fig E1, D) .
CD161 expression has been connected to the cytokineproducing capacity of FOXP3 1 cells. 11 Here, we demonstrate that the percentage of CD161 1 cells and CD161 expression among the FOXP3 1 population are significantly related to age (Fig 1, D and E; Fig E2, C) . Notably, S aureus-CFS induced an increased expression of CD161 by FOXP3 1 cells (Fig 1,  E) . We therefore investigated whether early-life S aureus colonization associated with CD161 expression at 2 years of age. Noncolonized children tended to have a lower percentage of CD161 1 cells within the FOXP3 1 population (Fig 2, A) and the amounts of S aureus at 3 different time points in early life positively correlated with the percentage of CD161 1 cells at 2 years of age (Fig 2, B) . S aureus amounts also positively correlated with the percentage of IL-10 1 cells among the FOXP3 1 population after stimulation (Fig 2, C) . We suggest that the age-related increased percentage of CD161 1 cells reflects a capacity for enhanced cytokine production by FOXP3 1 cells after microbial stimulation, supported by the observed increase in CD161 expression after S aureus stimulation in all age groups.
We have previously shown that lactobacilli-derived factors are able to dampen S aureus-induced activation of lymphocytes in vitro. 9 After costimulation of PBMCs with both S aureus-CFS and L reuteri-CFS, the activation of Furthermore, L reuteri-CFS dampened the secretion of IFN-g and IL-17A from PBMC cultures (Fig E3, C) . Of note, the capacity of L reuteri-CFS to dampen S aureus-induced activation was not related to age. Finally, the percentage of IL-10 1 cells among the FOXP3 1 population was lower in 2-year-old children that were colonized by lactobacilli in infancy (Fig 2, E) . Indeed, lactobacilli colonization associates with fewer IL-10-producing PBMCs after PHA stimulation. 8 Here, we show that FOXP3 1 T cells from children are impaired in microbial-induced cytokine-production, which possibly connects to a lower CD161 expression. The clear influence of bacterial products derived from S aureus and lactobacilli, which are present in the early gut of infants, on peripheral FOXP3 tion to lactobacilli colonization. *P < .05, **P < _ .01, ***P < _ .001, and ****P < _ .0001.
METHODS Ethics statement
Ethical permissions were obtained from the Regional Ethics Committee in Stockholm, Sweden (2014/2052-32; Dnr 04-106/1) and from the Human Ethics Committee at Huddinge University Hospital, Stockholm (Dnr 331/02 and Dnr 117/97). All study subjects or legal guardians gave their informed consent. All samples were handled as instructed in the approved ethical applications. It will not be possible to connect published data to any individual.
Subjects
In this study, we used material from healthy newborn children, 2-year-old children, 7-year-old children, and adults as described below. Twenty-five 2-year-old children were selected from a prospective birth cohort described in detail elsewhere. E1 Children were included on the basis of the presence of DNA from S aureus and a group of Lactobacillus strains (L rhamnosus, L casei, and L paracasei) in fecal samples at 3 occasions during infancy: age 1 week, 2 weeks, and 2 months.
E2 Immunological data were correlated with the presence/absence of lactobacilli or S aureus or with the relative amounts of S aureus in stool collected at the indicated time points of age expressed as percent bacterial DNA of total nucleic acids. All infants from the prospective birth cohort were born vaginally at full term, with normal birth weight, were exclusively breast-fed, and did not receive antibiotics during the first 3 months of life. The infants were without known health conditions, except for 7 children who were IgE-sensitized at 2 years of age; however, these children did not differ in any of the investigated immune parameters. In addition, mononuclear cells from healthy donors were collected at birth (cord blood, n 5 12, all vaginally delivered), 7 years of age (n 5 15), and adults (n 5 19, age 18-65 years) to investigate immune maturation in relation to age.
Cord/peripheral blood mononuclear cell isolation
Venous blood was collected in heparinized vacutainer tubes (BD Biosciences Pharmingen, San Jose, Calif). CBMCs/PBMCs were isolated by Ficoll-Hypaque (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) gradient separation. PBMCs were used directly or washed in RPMI-1640 and diluted in freezing medium containing 40% RPMI-1640, 50% FCS (Life Technologies-Gibco, Carlsbad, Calif), and 10% dimethyl sulphoxide (Sigma Aldrich, St Louis, Mo) and stored in liquid nitrogen until analyzed. 
Purification of human naive CD4 T cells and CD14
Bacterial strains
CFSs from S aureus 161:2 (expressing genes for staphylococcal enterotoxin A and H, kind gift from Asa Rosengren, the National Food Agency, Uppsala, Sweden) and L reuteri DSM 17938 (kind gift from Biogaia AB, Stockholm, Sweden) were kindly provided by Stefan Roos, the Swedish University of Agricultural Sciences. S aureus 161:2 was cultured in BHI broth (Merck, Darmstadt, Germany), and L reuteri DSM 17938 was cultured in MRS broth (Oxoid, 149, Hampshire, United Kingdom) and the CFSs were prepared as previously described. E3 
In vitro activation of PBMCs
CBMCs/PBMCs were thawed and washed before counting and exclusion of nonviable cells by Trypan blue staining. The cell viability was more than 90%. Cells were resuspended to 10 6 cells/mL in cell culture medium: RPMI-1640 supplemented with 20 mM HEPES, penicillin (100 U/mL), streptomycin (100 mg/mL), L-glutamine (2 mM) (all from HyClone Laboratories, Inc, South Logan, Utah), and 10% heat-inactivated FCS. The PBMCs were either rested for 2 hours (basal phenotyping) or incubated for 24 hours with cell culture medium alone or with 2.5% of CFS from either S aureus 161:2 or L reuteri DSM 17938 or both in combination in flatbottomed 96-well cell-culture plates (Costar, Cambridge, UK) with Monensin or Brefeldin A (BD Biosciences) present during the last 4 hours of incubation at 378C in 6% CO 2 atmosphere. Dynabeads Human T-Activator CD3/CD28-beads (Life Technologies, Carlsbad, Calif) used at 2:1 (cell:bead) ratio served as positive control. Alternatively, 2.5 3 10
5 PBMCs diluted to 1 3 10 6 cells/mL or 1 3 10 5 isolated, naive CD4 1 T cells diluted to 0.5 3 10 6 cells/mL in cell culture medium were stimulated with S aureus-CFS for 48 hours. Naive CD4
1 T cells were plated with 12,000 autologous monocytes.
Flow cytometry
Cells were stained with the LIVE/DEAD Fixable Dead Cell Stain Kit-Aqua (Life Technologies) and then incubated with 10% human serum in FACS-wash buffer (PBS, 2 mM EDTA and 0.1% BSA). Cells were stained with cell surface antibodies: CD4 FITC, CD25 APC-H7, CD45RA PE-Cy7, CD127 PE-Cy7, CD127 BV421 (all from BD Biosciences) or CD45RA FITC (ImmunoTools, Friesoythe, Germany) or CD161 PerCP-Cy5.5 (Biolegend, San Diego, Calif). For intracellular staining, the Transcription factor buffer set (BD Biosciences) was used according to instructions from the manufacturer. Cells were stained with FOXP3 PE, IFN-g PerCP-Cy5. 
Statistics
The GraphPad Prism 6 software (GraphPad Software, La Jolla, Calif) was used for statistical analysis. Groups were compared with the nonparametric Kruskal-Wallis test and if significant, comparisons between 2 groups were made with the Mann-Whitney U test. Comparisons of parameters within the same individual were made with the Wilcoxon matched pairs test or the Spearman rank correlation test. The differences were considered significant if P was less than .05 (*P < .05, **P < _ .01, ***P < _ .001, ****P < _ .0001). (Fig E2, A) , HELIOS 1 cells (Fig E2, B) , and CD161 1 cells (Fig E2, C) among the total CD4 1 (left column) or the CD4 1 FOXP3 2 (right column) T-cell populations. CB, Cord blood. *P < .05, **P < _ .01, ***P < _ .001, and ****P < _ .0001.
J ALLERGY CLIN IMMUNOL VOLUME nnn, NUMBER nn Secreted levels of all cytokines at unstimulated conditions were with no exceptions below the detection limits (not shown). FSC, Forward scatter. *P < .05, **P < _ .01, ***P < _ .001, and ****P < _ .0001.
